A
14.59
0.68 (4.89%)
| Previous Close | 13.91 |
| Open | 13.90 |
| Volume | 1,693,738 |
| Avg. Volume (3M) | 1,158,246 |
| Market Cap | 1,622,208,384 |
| Price / Sales | 0.660 |
| Price / Book | 5.94 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2026 |
| Operating Margin (TTM) | 16,317.06% |
| Diluted EPS (TTM) | -3.10 |
| Quarterly Revenue Growth (YOY) | -99.60% |
| Total Debt/Equity (MRQ) | 0.69% |
| Current Ratio (MRQ) | 12.05 |
| Operating Cash Flow (TTM) | -206.98 M |
| Levered Free Cash Flow (TTM) | -182.62 M |
| Return on Assets (TTM) | -40.72% |
| Return on Equity (TTM) | -83.24% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Bullish | |
| Stock | Amylyx Pharmaceuticals, Inc. | Bullish | Bullish |
AIStockmoo Score
0.4
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 0.38 |
|
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Growth |
| % Held by Insiders | 9.54% |
| % Held by Institutions | 85.89% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Saturn V Capital Management Lp | 31 Mar 2026 | 4,349,885 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |